|Articles|June 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-06-02-2003
  • Volume 27
  • Issue 6

Formulation Development of a Nucleotide Phosphoramidate

A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.
External Link - article-59281.pdf

Articles in this issue

over 22 years ago

June 2003

over 22 years ago

From Genome Exploration to Drug Development

over 22 years ago

Are you ready for Gen3

over 22 years ago

Enhancement of the Dissolution Rate and Bioavailability of Glipizide through Cyclodextrin Inclusion Complex

over 22 years ago

Behavior of Uptake of Moisture by Drugs and Excipients under Accelerated Conditions of Temperature and Humidity in the Absence and the Presence of Light

over 22 years ago

Outsourcing Outlook

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us